Strengthening Our Leadership Worldwide
The story of Bayer Consumer Care is one of evolution and growth and our Vision reflects the enduring strategy that has guided our efforts in recent years and our optimism about the future.
Our growth culture is characterized by an open approach to innovation, which we believe fuels the best opportunities and cultivates the vision for bringing them to market. In this model, new sources for growth go beyond core brand innovation to also include global and regional acquisitions, Rx-to-OTC switch initiatives, in-licensing partnerships and complementary joint ventures. This diversified approach is best illustrated by recent business developments including transformational growth endeavors such as the 2005 Roche Consumer Health acquisition; the 2007 purchase of the Citracal® calcium brand portfolio in North America; and the 2008 additions of Topsun Science & Technology’s leading Cough & Cold portfolio in China and Sagmel’s over-the-counter brand portfolio in the fast-growing Eastern European region.
R&D however, will always be central to our growth and innovation strategies. With a comprehensive approach, dedicated science professionals, strategic alliances and a dynamic global network of research and manufacturing centers, we’ll continue to bring the benefits of science into everyday life for consumers around the world.
Today, as a global leader, we take a proactive role in shaping the development of our industry and stand prepared to initiate and respond to change in an effort to benefit our consumers and our business. Aiming higher, reaching further, innovating and delivering results — these will always be the enduring qualities behind our growth story.
